# Implantation or Injectable Dosage Form New Animal Drugs; Tilmicosin Phosphate Injection
> **US Department of Health and Human Services** · Final rule. · Published 1997-02-06 · Effective 1997-02-06 · 62 FR 5526
## Document
- **Document number:** 97-3016
- **Category:** other
- **Sub-agency:** US Department of Health and Human Services
- **Federal Register citation:** 62 FR 5526
- **CFR reference:** 21 CFR 522
- **Publication date:** 1997-02-06
- **Effective date:** 1997-02-06
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, a Division of Eli Lilly and Co. The supplemental NADA provides for subcutaneous use of tilmicosin phosphate injection for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease (BRD) associated with Pasteurella haemolytica.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1997/02/06/97-3016/implantation-or-injectable-dosage-form-new-animal-drugs-tilmicosin-phosphate-injection)
---
*AI Analytics · CC0 1.0*